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Abstract 
Shared decision making places an emphasis on patient understanding and engagement. However, when it comes to 
treatment selection, research tends to focus on how doctors select pharmaceutical treatments. The current study is a 
qualitative assessment of how patients choose among three common treatments that have varying degrees of scientific 
support and side effects. We used qualitative data from 157 undergraduates (44 males, 113 females; mean age = 21.89 
years) that was collected as part of a larger correlational study of depression and critical thinking skills. Qualitative 
analysis revealed three major themes: shared versus independent decision making, confidence in the research and the 
drug, and cost and availability. Some participants preferred to rely on informal networks such as consumer testimonials 
while others expressed a false sense of security for over-the-counter treatments because they believe the drugs are 
regulated. Many indicated that they avoid seeking mental health services because of the time and money needed. The 
results indicate several factors influence selection of common depression treatments. Young adults indicate that when 
reading prescription information, they most often rely on perceptions including ease of access, price, and beliefs about 
drug regulations. General guidelines for treatment descriptions were created based on the qualitative analysis. 
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Introduction 
 
Over 60 million US residents search for health 
information online to inform their medical decisions, with 
more than 70% of them influenced by that information1. 
Moreover, 1 in every 3 who accesses the internet for 
health information will self-diagnose without ever seeing a 
medical professional.1 As more people use the internet 
each year to locate and self-diagnose health problems,2 it is 
important to determine what information in treatment 
descriptions is considered important and how that 
information is interpreted by the consumers. 
 
Online treatment descriptions vary widely based on the 
type of webpage that is marketing the treatment 
information.3 For example, a webpage dedicated to health 
information will tend to provide general materials related 
to maintaining a healthy lifestyle, or contain information 
related to treating a specific condition.3 In many cases, the 
information found online is inaccurate or incomplete, with 
some studies noting over 75% of the webpages that 
marketed health information were incorrect.3,4,5 Hansell 
and colleagues2 determined that websites focused on 
addressing mental health problems provided theoretically 
biased information about the treatments available. Despite 
the widespread misinformation, health-oriented websites 
have been shown to facilitate help-seeking behaviors.3,2  
 
Although research suggests that using health websites 
increases help-seeking behaviors, little is known about how 
the treatment information found on these websites affects 
utilization and compliance to treatment schedules, 
especially among young adults. More broadly speaking, 
there is little research addressing young adults’ general 
perspectives of treatment descriptions for mental health 
pharmaceutical drugs.6 Thus, the primary purpose of the 
current study is to determine what respondents perceive is 
the most salient and important information presented 
within mental health treatment descriptions and how that 
influences their treatment selection. The results of this 
research will help inform how to display medication 
information to young adult consumers to encourage 
utilization of efficacious mental health treatments when 
needed. 
 
Treatment Selection in the Health Decision Making 
Process 
There are numerous factors that influence a person’s 
treatment selection in the health decision making process. 
Jorm and colleagues7 suggest that the public often bases its 
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opinions of treatments on general belief systems, which 
are not typically supported by empirical research. For 
example, some people believe that professional mental 
health services are worse than getting no help for mental 
issues.7 Others seek out informal networks of family and 
friends for information regarding health choices.7 In these 
cases, people are relying on the personal experience of 
known individuals to aid their decision process instead of 
deferring to a potential stranger (e.g., a doctor). Since these 
referrals are generally rated more positively than referrals 
from medical professionals,7 they can influence whether a 
person utilizes empirically supported treatment versus a 
pseudotreatment. It is thought that this reliance on an 
informal network instead of medical professional’s opinion 
could be part of the reason that fad treatments have seen a 
rise in popularity and are a highly sought-after treatment 
option.8  
 
The acai berry is one such fad treatment, or 
pseudotreatment, that is marketed for a variety of health-
related issues, including mental health problems.9 The 
popularity of this drug could be due to promotional 
websites that includes information about how this berry is 
used to treat a wide range of ailments including high blood 
pressure and weight loss.9,10 Likewise, natural health stores 
tend to carry acai berry supplements because of other 
putative health benefits, such as reducing cancer risk, 
improving depression symptoms, and increasing sexual 
performance.11 While such information has broad appeal, 
there is very little research to support these purported 
health benefits.  
 
These natural remedies are highly sought after, particularly 
by young adults who are often consumers of alternative 
medicines.12 How young adults choose among treatment 
options is of particular interest because 18-25 years of age 
is considered a critical time to develop healthy personal 
care habits, including both physical and mental care.13 
These young adults are not only at risk of suffering from 
poor mental health, but are also at risk of developing poor 
health decision making skills, which could have lifelong 
implications.  
 
To help young adults make better health decisions based 
on information obtained online or through informal 
networks, we sought to identify the components of 
treatment information that are perceived as most salient 
and influential. Determining how young adults view 
treatment information can provide insight for modelling 
future treatment descriptions increase young adults’ 
selection of efficacious mental health treatments over 
pseudotreatments.  
 
Method 
 
This study was conducted at a mid-sized, urban state 
university as part of a large mental health treatment 
selection survey that utilized mixed methodology. The 
relationship between critical thinking skills and mental 
health treatment selection was evaluated using quantitative 
methods, which is reported elsewhere.14 Qualitative data 
(reported in the current article) allowed the opportunity 
for analyzing participants’ rationales for selecting one drug 
description over two other drug descriptions. Table 1 
includes the three treatment descriptions based on 
Selective Serotonin Reuptake Inhibitors (SSRIs), St. Johns 
Wort, or acai berries that were provided to each 
participant. Each description was segmented into five 
sentences and masked as Drug A, B, or C for a “general 
mental health issue” to avoid any bias that could have 
been introduced by providing the real drug name. The 
order in which sentences were presented was randomized 
for each participant.  
 
Each sentence within the drug description was designed to 
relate to one of five specific critical thinking domains.14 
The statements included structural keywords that were 
used as the basis for the qualitative analysis discussed in 
the current article. Participants were shown three 
statements at a time, one from each drug description. 
After selecting the statement, they preferred, participants 
were asked to provide their rationale for the selection in an 
open-ended comment box. This was repeated until all five 
individual selections were made and comments were 
provided. 
 
After individual selections were finished, the complete 
treatment descriptions were provided. The first full 
description was shown to participants using masked 
names, presented as Drug A, B, and C. To determine if 
participants would change their selection based on name 
recognition, the second full description included the actual 
treatment names (SSRIs, St. Johns Wort, and acai berries). 
Again, for each of these presentations, participants 
selected which drug they preferred and provided their 
rationale. The selection and comment process resulted in 
seven distinct comments maximum per participant, which 
range from no response provided to full paragraphs of 
text. By asking for participants’ opinions on each of the 
five statements, as well as the overall statements, we were 
able to analyze what information was most salient during 
the selection process. 
 
Participants 
In total, a random sample of 157 undergraduates from a 
wide range of academic majors (44 males, 113 females) 
ranging from 18- to 66-years-old (M = 21.89 years, median 
= 19 years, SD = 7.382 years) were eligible and completed 
all study requirements. The ethnic demographics were 
diverse and representative of the overall student 
population at the university: 64% of the sample indicated 
they identified as White, 13% Black, 5% Hispanic, and 
19% identified as some other ethnicity. Therefore, the 
results could be generalizable to the student population 
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from which they were drawn. These results may also 
generalize to young adults in other collegiate settings based 
on comparable demographics. 
 
 
Ethical Considerations 
The study was approved by a university ethics committee. 
The informed consent emphasized voluntary participation 
and maintenance of confidentiality. All participants signed 
the informed consent via a digital signature prior to 
completing the survey. They were also provided disclosure 
information and signed a confidentiality agreement after 
completing the survey. 
 
Data Analysis 
The qualitative data were analyzed using the grounded 
theory method. This method requires marking key points 
in the data through a series of codes, which were derived 
directly from the empirical data.15 Researchers drew 
deductive codes based on the treatment selection 
statements provided to participants and then derived 
additional 1-3 word phrases directly from the comments to 
evaluate emerging patterns. The codes were grouped 
thematically based on overlapping concepts and ideas.16 
After coding and grouping was completed, the concepts 
were analyzed to determine overarching categories and 
themes for discussion.16 
 
Results 
 
Overview of Results 
When structural keywords were removed for comment 
analysis, three distinct themes were found that focused on 
multiple aspects important to the participant’s treatment 
selections in the health decision making process: Shared 
versus Independent Decision Making, Confidence in the Research 
and the Drug, and Cost and Availability. The major points 
from each theme are summarized in Table 2 based on the 
drug selected. In general, participants focused on 1-3 
major themes throughout their individual responses, and 
many of the themes crossed over the same topics. There 
were overarching themes about safety and personal health, 
which were differentially discussed in each of the three 
treatment selection groups as part of the three major 
themes. 
 
 
Table 1. Treatment descriptions statements and structural keywords 
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Shared versus Independent Decision Making in the 
Treatment Selection Process 
Respondents expressed personal feelings toward 
prescriptions and doctors; specifically, if they prefer to rely 
on their own research and experience or would rather have 
recommendations from medical professionals. Those who 
selected SSRIs indicated a preference for deferring to a 
medical professional to make the treatment selection for 
them, whereas those who selected St. John’s Wort or acai 
berries preferred to have more control and autonomy in 
the treatment selection process. 
 
Participants who selected SSRIs indicated a general 
reliance on advice from medical professionals and seemed 
to defer to doctors’ expertise and judgment when making 
medical treatment decisions. Many of these participants 
indicated that they preferred SSRIs to the other two 
options because it was available by “prescription only.” One 
respondent went even further by stating that “all drugs 
should be taken with the advice of a medical professional and not self-
prescribed (even if over-the-counter)” with the exception of 
painkillers and antihistamines. Another stated that if a 
medical professional did not prescribe the drug, then there 
would be no way of knowing how it could affect current 
medication regimens.  
 
These responses suggest there was a need for 
accountability and security that participants felt could only 
be provided by medical professionals. The explicit 
statement that professionals would be aware of any 
possible drug interactions indicated that participants might 
have felt that only medical professionals would know what 
is detrimental to the patient. In general, those who selected 
SSRIs expressed that physicians are a type of gatekeeper 
for drugs that really work, which makes physicians more 
reliable and trustworthy than an individual making his or 
her own choice based on limited information. This sense 
of trust in medical professionals seemed to comfort 
participants who selected SSRIs and allowed them to 
remove themselves from the treatment selection process. 
 
Respondents who selected St. John’s Wort were also 
concerned with the potentially negative impact drugs have 
on health. One person stated that “just because it's prescribed 
doesn't mean it's the best for you, homeopathic is better.” This 
statement suggested a preference for natural remedies, 
which were perceived as safer than the pharmaceutical 
option. However, these respondents also indicated a 
consensus that some medical support is better than none at 
all. Even with preferring natural treatment options, they 
were hesitant to select a drug that does not have any 
professional support. In addition to using natural remedies 
that have some research support, these respondents 
indicated a desire to avoid the “hassle” associated with 
scheduling a doctor’s appointment and waiting to pick up 
prescriptions. They trusted that St. John’s Wort is “the most 
safe” and that over-the-counter accessibility is the most 
“convenient” because it could reduce symptoms while 
remaining easily accessible. One respondent stated: 
 
By being an over-the-counter drug, it is much more 
convenient to buy and use, compared to the process and 
time it takes to see a doctor to get a prescription. The 
drug is recommended by medical professionals which 
supports the assumption that the drug is effective and 
therefore, because of convenience and recommendation, 
this one seems like the best choice. 
 
Another respondent stated: 
 
Medication is not something I would purchase online, 
and assuming the over the counter variety is just as 
effective, I would prefer to get a medication without need 
for a “medical professional.” 
 
Even though those who selected acai berries also wanted 
to avoid the hassle associated with scheduling 
appointments and getting prescriptions filled, these 
participants had a strong need to be “in control” of 
themselves and their own treatment selection and health 
decision making processes. Likewise, they preferred 
natural remedies over pharmaceutical options. One 
participant stated, “this treatment is the most natural which 
means it is less harmful” than the other two treatment 
options. Participants who preferred the acai berries did not 
mention anything about the research supporting the drug, 
Table 2. Summary points of major themes 
 
 
Young adult selection of mental health pharmaceuticals, Talboy et al. 
  
 
Patient Experience Journal, Volume 3, Issue 2 - Fall 2016 41 
or lack thereof in this case. These respondents seemed to 
focus more on starting with the simplest treatment option 
first, and moving on to other options at a later time if 
needed.   
 
Confidence in Research and the Drug 
In addition to the type of preferred decision making style 
enacted for the treatment selection process, respondents 
indicate they were interpreting the research and medication 
regulation process as it related to the treatment 
descriptions. This theme was particularly relevant to 
participants who selected SSRIs because they often 
focused on the scientific aspect of research that supported 
the drug. Participants who selected St. John’s Wort and 
acai berries were not differentiated in this theme as they 
both commented on aspects that were not directly 
influenced by the research supporting their drug of choice.  
 
Those who chose St. John’s Wort or acai berries indicated 
that scientific research should be more trustworthy than 
consumer reviews, but generally prefer the consumer 
reviews just the same. One participant states “even though I 
shouldn’t trust consumer reviews, I’ve learned to trust them more than 
“rigorous scientific research” at least from a consumer’s point of 
view.” This commenter’s use of quotations around rigorous 
scientific research suggests ambivalence, or possibly 
disdain, toward the research process. The caveat expressed 
concern that consumer reviews should be trusted less than 
scientific research. However, the participant indicated one 
cannot help but ignore gut instincts to rely on scientific 
research because personal experience revealed consumer 
testimonials were more reliable. This is alarming 
considering that many homeopathic treatments rely on 
informal consumer reviews to promote use. 
 
Even with the general dismissal of scientific evidence, 
respondents who selected St. John’s Wort or acai berries 
indicate a belief that there is some form of regulatory body 
overseeing these over-the-counter drugs and that they rely 
on that regulation to ensure over-the-counter drugs are 
safe. One respondent states “my limited understanding of the 
[Federal Drug Administration (FDA)] indicates to me that drugs 
available over the counter have been tested and approved for common 
use.” This is a common misconception among people who 
take over-the-counter drugs as opposed to prescriptions, 
despite the warnings that many over-the-counter drugs, 
such as health supplements and diet pills, are not 
necessarily regulated by the FDA. 
 
Respondents who chose the SSRI expressed much greater 
appreciation for the research process than participants 
who selected the other two drugs. One participant stated 
that the SSRIs had “more positive information than others,” but 
other commenters provided much more detail. One such 
example stated that the SSRI option: 
 
. . . shows more scientific research that backs it up and 
evidence. It has reported side effects, indicating it has 
been thoroughly studied and surveys have been 
conducted. The percentage of positive measurable 
results is decent and significant, for there is a chance 
of seeing a difference by taking this drug both 
physiologically and mentally. It is also prescribed 
under the care of a medical professional, meaning that 
you yourself are being monitored, and under the care 
and treatment of usually a doctor, which would make 
me feel more safe in taking this drug, rather than 
something OTC. 
 
This respondent reflected on the benefits provided by the 
scientific process. There was a general feeling of safety 
knowing that the drug has been thoroughly vetted by 
decades of research, and that it is regulated as a medication 
available only through a prescription. These participants 
discuss the need for considering the medical professional’s 
opinion as well as the safety provided by professionals 
monitoring drug use, in case there were any problems or 
interactions with other current medications. 
 
Cost and Availability 
Many of the comments discussed the expenditure of time 
and monetary resources, as well as how those costs 
affected the respondents’ treatment selection. This theme 
clearly differentiated the participants who chose SSRIs 
from the participants who chose St. John’s Wort. 
Interestingly, this theme was only briefly discussed by 
participants who selected acai berries, mainly referencing 
the aversion to spending time in doctor’s offices and 
waiting for prescriptions. It is possible that these 
respondents were not concerned with the monetary costs 
associated with their drug selection, but further research 
will be needed to determine the extent to which cost and 
availability affect one’s selection of acai berries over St. 
John’s Wort or SSRIs. 
 
Participants who selected SSRIs focused primarily on how 
the drug can be obtained only through prescription and 
that it must recommended by medical professionals. These 
respondents mentioned that the higher cost typically 
associated with this drug would be acceptable because of 
the benefits received by utilizing a medical professional for 
treatment. One participant remarked that: 
 
I chose the [SSRIs] overall because I would want 
something that is in fact effective, even though it would 
most likely cost more, I would also be monitored by 
checking in with my medical professional, and be able 
to discuss any side effects. The physician is more likely 
to be more educated about this drug, especially if he or 
she is prescribing it, for not only accountability 
purposes, but medical ethics, so I would definitely go 
with [SSRIs]. 
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The commenter is concerned with the multiple aspects of 
the treatment, including the effectiveness, progression of 
treatment, and knowledge of the medical professional. 
This indicates that the participant was concerned with 
future problems that could occur, such as the side effects, 
and how to proactively prevent issues from occurring by 
relying on a medical professional, even though this could 
cost more in the short- and long-term.  
 
Another participant who selected SSRIs chose this drug 
because it is available by “prescription only and you would have 
to see a doctor to get a script.” For respondents who provided 
similar comments, there was a general consensus that 
controlled access to the drug meant that the drug would 
“probably work better” than a drug that is available over the 
counter.  This indicates a belief that pharmaceuticals are 
more reliable than homeopathic treatments, which may 
mentally offset the added cost of time and money needed 
to acquire this treatment. 
 
Participants who selected St. John’s Wort preferred 
homeopathic treatments that were easily accessible, as 
discussed in the other themes. These participants focused 
on how the drug is available over-the-counter, which 
meant it is probably had a “better price range” than drugs 
available by prescription only. In addition to the time 
needed to schedule and wait for appointments, 
respondents focused on the cost of seeing a doctor which 
could be used to try alternative treatments instead. These 
respondents agreed that going to a doctor is “too expensive” 
and if it was available over the counter without a 
prescription while still being recommended, then it “will 
usually be safe, non addicting, and maybe inexpensive.” One 
commenter argued that: 
 
[I] would choose a drug that is only available by 
prescription if we currently had socialized medicine in 
our country and visiting a doctor was low cost, but until 
that kicks into full-effect, I'd opt for an over the counter 
drug and skip the doctor visit altogether. 
 
Several other responses indicated that this drug “is more 
readily available” because it does not require a prescription 
to purchase. Likewise, some respondents indicated that 
having supporting research still influenced their selection, 
but they preferred the supported drug that is available 
without going to the doctor and is therefore easier to 
access. 
 
Discussion 
 
The results provide insight into the treatment selection 
process and what information may influence that process 
from the young adults’ point of view. The majority of 
these respondents were female and at an age when critical 
medical decision making skills are being developed,13 
allowing us to focus on elucidating what they felt was the 
most important and influential information within the 
treatment descriptions. However, the breadth and depth of 
the comments and emerging themes indicate that the 
points raised have the potential to be important to all 
young adults. Despite being given several key words such 
as research and side effects, respondents provided detailed 
information that went beyond these codes and applied 
across overarching themes of safety and personal health, 
both of which applicable to most young adults. The topics 
(shared versus independent decision making, confidence in 
research, and costs) that evolved from these descriptions 
can be used to enhance online presentations of mental 
health treatment descriptions that facilitate informed 
health decision making among young adults. 
 
Guidelines for Modeling Treatment Information 
Based on the comments provided by participants, we 
found three major areas of information within treatment 
descriptions that are salient to young adults. Based on 
analysis of these areas, we present general guidelines for 
how that future treatment descriptions can be improved to 
increase selection of efficacious treatments over 
pseudotreatments. First, addressing the amount of 
autonomy and self-directed assessment of available 
treatments allowed in the treatment selection process may 
increase utilization of empirical treatments. Second, 
incorrect impressions about the research process and 
overseeing regulatory agencies can be corrected through 
clear labeling. Third, knowledge about the cost and 
availability not only of the drug but also of the doctors and 
their offices can be increased through targeted outreach 
campaigns. Each is discussed in further detail below. 
 
Information-seeking and autonomy in the treatment 
selection process. Patient-centered care and shared 
decision making is popular and desirable to many people, 
but there is research suggesting some patients prefer a 
more paternalistic approach to decision making (i.e., 
deferring to a medical professional).17 We noted this 
pattern among individuals in the current study with regard 
to the treatment selection process. Those who preferred 
SSRIs aligned with a more paternalistic approach to 
treatment selection, whereas those who preferred St. 
John’s Wort or acai berries preferred more autonomy in 
the treatment selection process. For example, participants 
who selected SSRIs focused on the importance of having a 
medical professional involved and controlling the decision 
process because of safety concerns about the drug and 
possible interactions. They also noted the presence of 
supporting scientific research creates a sense of trust in the 
drug and a pervasive belief that the drug will do what it 
was created to do because it is regulated (i.e., only available 
through a prescription despite increased costs). 
Alternatively, those who selected St. John’s Wort or acai 
berries preferred the ease of access and lower costs 
associated with over-the-counter medications, which does 
not necessitate direct involvement of a healthcare 
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provider. These participants had preconceived notions 
about the safety of using empirically supported treatments, 
with many indicating a perception that homeopathic 
treatments are safer.  
 
Young adults who have preconceived notions about 
available treatments (which could potentially be incorrect 
or incomplete) may be educated through modification of 
treatment descriptions and inclusion of information about 
the wide range of treatment options available. For 
example, it is important to convey to patients that there 
are dozens of medications that fall under the broad 
category of SSRIs.24 Additionally, there are the brand name 
versions of the drugs as well as generic versions.24 Even 
though these are all well-regulated treatments requires a 
prescription, young adults may appreciate having the 
choice to select among several empirically supported 
treatments. Introducing choice into the treatment selection 
process may provide a sense of autonomy, which in turn 
may increase uptake of empirical treatments over 
pseudotreatments. Increased feelings of autonomy can also 
be achieved through provision of enhanced treatment 
descriptions (either in an analog form such as a pamphlet 
or digital form such as an information portal) describing 
and comparing several different treatment options.  
 
Enhanced treatment descriptions are beneficial for a 
variety of reasons. For example, enhanced treatment 
descriptions could acknowledge the different cost 
structures of treatments (e.g., with or without insurance, 
pharmaceutical discount programs), which would address 
concerns related to pricing of the treatment. If information 
is available on accessibility, this could be included in the 
enhanced description as well. In addition to providing a 
sense of control, enhanced treatment descriptions could 
also be used to provide information about the efficacy of 
each prescription, supporting (or contradicting) research 
for the treatment, and relevant consumer testimonials. 
Although testimonials are not traditionally provided in 
prescription information sheets, many participants in the 
current study indicated that they prefer this informal 
review to scientific evidence. Therefore, including this 
information for each empirically supported treatment may 
increase selection of an efficacious treatment over a 
pseudotreatment.  
 
Research and regulatory agencies. Participants who 
selected St. John’s Wort preferred to avoid the arduous 
process of getting a prescription drug but still wanted the 
benefit of supporting scientific research. However, these 
participants noted the belief that over-the-counter drugs 
are regulated by organizations such as the FDA, which 
implies they believe these drugs are safe for consumption. 
While St. John’s Wort supplements are regulated in 
European countries such as Germany (where it is a highly 
recommended over-the-counter treatment for depression 
and anxiety), it is not regulated like prescriptions and over-
the-counter medications in the US because it is classified 
as an herb.18 Knowing that young adults may have a false 
sense of security because they believe the drug is regulated 
provides insight into what information should be 
presented in treatment descriptions. Treatment 
descriptions of all potential medications, including 
pseudotreatments and supplements, should clearly indicate 
if the drug is overseen by a regulatory agency. 
 
Braun and colleagues19 suggests that pharmacists may be 
the best point of entry for an oral discussion about 
homeopathic drug safety, and thus regulatory oversight, 
with young adults because aversion to doctors does not 
appear to extend to pharmacists. In fact, people are more 
likely to disclose all medication usage, including 
unsubstantiated treatments like acai berries, to their 
pharmacist as a means to avoiding unpleasant drug 
interactions.19 This could create the opportunity for open 
and frank discussions about the benefits of empirically 
researched drugs over pseudotreatments. Likewise, this 
could provide the opportunity to teach young adults about 
the lack of oversight by regulatory agencies on over-the-
counter treatments such as St. John’s Wort. These medical 
professionals can proactively guide their patients by 
providing appropriate, accurate, and complete medical 
information regarding different treatment options.20,21 
 
Addressing costs and availability. Many young adults 
indicated that they wish to avoid the hassle and cost 
associated with visiting the doctor, filling a prescription, 
and complying with medical monitoring while receiving 
treatment for mental health issues. However, young adults 
might not realize the range of medical treatment options 
that are available to them, especially college students who 
have access to university resources.13 These university 
resources include low or no-cost treatment options 
available through the on-campus health and behavioral 
health centers.13,22 Many campuses also offer counseling 
services at no charge to students, which could alleviate 
part of the concern mentioned by these participants. 
Getting young adult students to these resources may be as 
simple as advertising their availability. This could be 
accomplished through concerted efforts by the university 
health clinics. For example, emails sent out toward the 
beginning of each semester when students enroll for 
classes each year could include important information 
about the health services available on campus. These 
targeted emails may also benefit from including the 
associated cost and benefit structure of utilizing campus 
health resources. Additionally, posters may increase 
exposure to information about the health clinics if they are 
in highly visible areas with a lot of student traffic (such as 
the dining hall).  
 
For young adults who do not have access to university 
health systems, there are other low-cost or free options 
available in many communities. This includes community 
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health clinics and clinics that offer services on a sliding 
scale. Additionally, pharmaceutical treatments for mental 
health disorders need not be full price for all individuals 
who take them. For example, Walmart and Target offer 
generic versions of some antidepressants for $4/month or 
$10 for a three-month supply.24 There are also many 
pharmaceutical companies that will provide deeply 
discounted vouchers for patients who demonstrate a 
financial need. Increasing access to this information may 
help increase use of empirically-supported drugs over 
pseudotreatments. Because many young adults seek out 
health information online, the information portals could 
potentially play a key role in presenting community-based 
treatment centers and low or no-cost prescription 
alternatives. 
 
Future Directions 
 
The results of the current study have indicated several 
avenues for future research. In addition to the directions 
discussed above, future research could also evaluate 
differences between males and females in treatment 
preferences and how those differences affect the treatment 
selection process. The role of education in the treatment 
selection process, and determining if the results are 
generalizable to other populations such as older adults are 
also potential areas of future research. Each point is briefly 
addressed. 
 
In the current study, our sample included a 2:1 female to 
male ratio, which was representative of the student 
population from which the sample was drawn but not the 
overall young adult population. To determine if the 
findings generalize well to a broad young adult population, 
a follow-up study could be conducted with equivalent 
sampling from each sex. Some research suggests that there 
are few, if any, differences between males and females in 
patient acceptance of treatment.25 However, others have 
demonstrated differences between the sexes for utilization 
of specific treatment options, such as surgery.26 Therefore, 
an important next step will be determining if males and 
females differentially weight certain treatment description 
components during the treatment selection process.  
 
Additionally, the study was conducted on a representative 
sample of young adults from a university population, 
which may not adequately represent all young adults. 
Higher exposure to research terminology during collegiate 
education may have cued our participants in to key terms 
which may not be as salient in a sample with lower 
education levels. However, our sample was a diverse group 
of young adults who ran the spectrum of decision making 
from the fully shared model to the paternalistic model. 
Furthermore, they elaborated on key issues such as cost 
and accessibility, which may be relevant to most young 
adults. Therefore, these findings may be applicable to a 
broader population. More research is needed to explore 
differences in treatment selection among young adults with 
different levels of education. 
 
Finally, preferences of young adults are often drastically 
different from those of older adults on a wide range of 
topics including autonomy and information-seeking 
behaviors for medical decisions.27,28 The current study was 
designed to assess what young adults perceive as the most 
salient information within treatment descriptions. We 
predicted that these findings would not be applicable to an 
older adult population, and tested that prediction in a 
follow up study not reported here. As expected, older 
adults hold very different views about how to select 
pharmacological treatments for mental health issues 
(Talboy & Guttmann, unpublished manuscript). 
Therefore, the results found here are relevant specifically 
to a young adult population. Additional research is needed 
to elucidate differences between how younger and older 
adults approach the treatment selection process. 
 
Summary 
 
Several insights into how young adults interpret material 
related to the selection of pharmaceutical treatments for 
mental health issues were outlined with implications for 
what should be addressed in mental health treatment 
descriptions. These insights suggested several important 
pieces of information to include in future treatment 
descriptions. First, access to information about the wide 
range of treatment options available is important for 
informed decision making (including brand name and 
generic alternatives). Second, enhanced treatment 
descriptions for each drug, potential side effects, and 
scientific support could include complementary reviews 
from consumers and consumer advocates. These informal 
reviews are preferred to scientific findings by many young 
adults and aid treatment selection. Finally, increasing 
general knowledge about available medical resources, 
especially low-cost or no-cost doctor’s offices and 
prescription drugs, may increase selection of empirical 
treatments over pseudotreatments. 
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